Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.

Blood - 1 Mar 2007

Bray Paul F, Howard Timothy D, Vittinghoff Eric, Sane David C, Herrington David M

Abstract excerpt

Millions of women still use postmenopausal hormone therapy (HT). We genotyped 2090 women in Heart and Estrogen/progestin Replacement Study for functional polymorphisms in GP1BA and GP6 and assessed the coronary heart disease (CHD) event rate over 5.8 years of follow-up. In patients receiving placebo, there was an increased CHD death/myocardial infarction (MI)/unstable angina (UA) event rate in carriers of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Disease
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Replacement Therapy

Share to Estrogens

Share to Membrane Glycoproteins

Share to Platelet Glycoprotein GPIb-IX Complex

Share to Platelet Membrane Glycoproteins

Share to Postmenopause

Source

Open in PubMed Open full text

Identifiers

PMID: 17105818
DOI: 10.1182/blood-2006-03-013151
PMCID: PMC1801053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.PMID 17105818Read ↗

Platelet glycoprotein Ibalpha polymorphisms modulate the risk for myocardial infarction.Semantic proximity Read ↗

Association of Platelet Membrane Glycoprotein HPA-2a/b, GP VI T13254C, and GP Ibα VNTR Polymorphisms with Risk of Coronary Artery Disease: A Meta-Analysis.Semantic proximity Read ↗

Polymorphisms in the platelet-specific collagen receptor GP6 are associated with risk of nonfatal myocardial infarction in Caucasians.Semantic proximity Read ↗

Platelet reactivity and genetics down on the pharm.Semantic proximity Read ↗

Polymorphisms in GP6, PEAR1A, MRVI1, PIK3CG, JMJD1C, and SHH Genes in Patients with Unstable Angina.Semantic proximity Read ↗

Role of platelet glycoprotein polymorphisms in cardiovascular diseases.Semantic proximity Read ↗

The impact of the glycoprotein Ia collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction.Semantic proximity Read ↗

Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation.Semantic proximity Read ↗

Glycoprotein Ia 807TT/873AA genotype is not associated with myocardial infarction.Semantic proximity Read ↗

HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction.Semantic proximity Read ↗

Clinical and functional consequences of platelet membrane glycoprotein polymorphisms.Semantic proximity Read ↗

Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.